Cargando…
Impact of FAK Expression on the Cytotoxic Effects of CIK Therapy in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is a special subtype of breast cancer in which several common diagnostic biomarkers are lost. Due to the loss of expression of receptors, treatment options for TNBC are limited. Therefore, finding safe and effective treatments for patients with TNBC is a major ob...
Autores principales: | Pan, Mei-Ren, Wu, Cheng-Che, Kan, Jung-Yu, Li, Qiao-Lin, Chang, Shu-Jyuan, Wu, Chun-Chieh, Li, Chung-Liang, Ou-Yang, Fu, Hou, Ming-Feng, Yip, Hon-Kan, Luo, Chi-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017032/ https://www.ncbi.nlm.nih.gov/pubmed/31905966 http://dx.doi.org/10.3390/cancers12010094 |
Ejemplares similares
-
Correction: Pan et al. Impact of FAK Expression on the Cytotoxic Effects of CIK Therapy in Triple-Negative Breast Cancer. Cancers 2020, 12, 94
por: Pan, Mei-Ren, et al.
Publicado: (2021) -
FAK is Required for Tumor Metastasis-Related Fluid Microenvironment in Triple-Negative Breast Cancer
por: Pan, Mei-Ren, et al.
Publicado: (2019) -
FAK Regulates VEGFR2 Expression and Promotes Angiogenesis in Triple-Negative Breast Cancer
por: Shiau, Jun-Ping, et al.
Publicado: (2021) -
CD300LG improves the cytotoxic activity of CIK
por: Wang, Qiuyue, et al.
Publicado: (2017) -
CHD4 as an important mediator in regulating the malignant behaviors of colorectal cancer
por: Chang, Chia-Lo, et al.
Publicado: (2021)